Champions Oncology, Inc. Q1 FY2026 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2026 Q1 Call date: 2025-09-15 Concluded

Quarter scorecard

Revenue

$13.99M

-0.5% YoY

Diluted EPS

$-0.03

-133.3% YoY

Net income

-$436,000

-133.2% YoY

Pharmacology Services $13.23M

+1.2%

Product And Service Other $454,000

-54.2%

Translational Oncology Solutions TOS License Revenue $311,000